```html

Zigzag Scar Tissue (Keloid Variant) – A Patient‑Focused Guide

Overview

Zigzag scar tissue, also referred to as a “keloid variant,” is an atypical form of keloid in which the scar does not grow in a smooth, rounded shape but instead forms irregular, angular or “z‑shaped” extensions that can spread outward from the original wound. Like classic keloids, these lesions are composed of excessive collagen deposition, but their distinctive morphology can make them harder to diagnose and treat.

Who it affects:

• Most common in people of African, Asian, or Hispanic descent (incidence up to 15 % in Afro‑Caribbean populations vs. <1 % in Caucasians) <sup>1</sup>.
• Usually appears between the ages of 10–30, though it can develop at any age.
• Women may be slightly more prone than men, possibly due to hormonal influences on wound healing<sup>2</sup>.

Prevalence: While exact numbers for the zigzag variant are not well captured in epidemiologic studies, it is estimated to account for <5‑10 % of all keloid presentations, based on dermatology clinic series<sup>3</sup>. Overall, keloids affect 2–16 % of the worldwide population, with higher rates in darker‑skinned groups.

Symptoms

Zigzag keloids share many symptoms with typical keloids but have a few unique features.

Common signs

• Elevated, firm tissue that extends beyond the original incision or injury.
• Irregular, angular borders that can appear like a series of connected triangles or “Z” shapes.
• Red, pink, or hyperpigmented surface (color may darken with sun exposure).
• Itching or burning sensation—reported in up to 70 % of patients with keloids<sup>4</sup>.
• Localized pain when the scar is stretched or touched.
• Reduced flexibility of nearby skin, especially over joints.

Less common manifestations

• Ulceration or breakdown if the scar becomes extremely thick.
• Secondary bacterial infection (redness, warmth, purulent discharge).
• Psychological distress—self‑consciousness, anxiety, or depression related to appearance.

Causes and Risk Factors

The exact pathophysiology of keloid formation is multifactorial, and the zigzag pattern appears to stem from irregular tension lines and fibroblast activity.

Underlying mechanisms

• Excessive collagen synthesis driven by overactive fibroblasts, especially type III collagen early on, later transitioning to type I.
• Dysregulated signaling pathways—TGF‑β, SMAD, and Wnt/β‑catenin pathways are up‑regulated, promoting scar tissue proliferation<sup>5</sup>.
• Mechanical tension—When a wound lies along a line of skin tension (Langer’s lines), fibroblasts may orient collagen in a jagged pattern, leading to the zigzag morphology.

Risk factors

• Genetic predisposition (family history of keloids).
• Dark skin pigmentation.
• Age 10–30 years (peak fibroblast activity).
• Previous keloid or hypertrophic scar formation.
• Severe acne, piercings, ear cartilage injuries, or surgical incisions that are sutured under tension.
• Delayed or improper wound care (infection, chronic inflammation).
• Hormonal influences (e.g., pregnancy, oral contraceptives) may exacerbate growth.

Diagnosis

Diagnosis is primarily clinical, supported by history and physical examination. A biopsy is rarely needed but may be performed to rule out malignancy when the lesion is atypical.

Clinical assessment

• Inspection of scar shape, color, and spread beyond wound margins.
• Palpation to assess firmness and depth.
• Documentation of symptom duration and any prior treatments.

Adjunctive tests

• Dermatoscopy – helps differentiate keloid from dermatofibroma or nodular melanoma.
• Ultrasound – high‑frequency (20‑MHz) probes can measure scar thickness and vascularity.
• Biopsy – incisional or punch biopsy if there is suspicion of a neoplastic process; histology shows thick, hyalinized collagen bundles extending into the reticular dermis.

Diagnostic criteria (simplified)

1. Scar extends >2 mm beyond original wound boundaries.
2. Firm, raised tissue with a characteristic zigzag or angular outline.
3. Absence of systemic disease that could explain the lesion.
4. History of exacerbation after trauma or surgery.

Treatment Options

Treatment is often multimodal; a single approach rarely eradicates a keloid completely. Early intervention improves outcomes.

First‑line therapies

• Silicone gel sheeting or sheets – applied 12–24 h/day for 3‑6 months; reduces erythema and flattening in ~50 % of cases<sup>6</sup>.
• Pressure therapy – custom pressure garments (20‑30 mmHg) for 12‑24 h/day, especially after ear or chest surgery.
• Topical corticosteroids – clobetasol propionate 0.05 % applied 2 times daily for 4‑6 weeks; useful for small, early lesions.

Procedural options

• Intralesional corticosteroid injections (triamcinolone acetonide 10‑40 mg/mL) every 4‑6 weeks; reduces size in 50‑80 % of keloids<sup>7</sup>.
• Laser therapy – Pulsed‑dye laser (PDL) or fractional CO₂ laser can flatten and improve color; typically 3‑5 sessions spaced 4‑6 weeks apart.
• Cryotherapy – Liquid nitrogen applied for 10‑30 seconds; may be combined with intralesional steroids.
• Radiation therapy – Low‑dose external beam post‑excision (10–15 Gy total) lowers recurrence to <15 % but is used sparingly due to long‑term cancer risk.
• Surgical excision – Reserved for large, refractory nodules; must be combined with adjuncts (radiation, steroids, silicone) to curb recurrence (up to 70 % without adjuvant therapy).
• 5‑Fluorouracil (5‑FU) or Bleomycin injections – Antimetabolites that inhibit fibroblast proliferation; often used with steroids.
• Immunomodulators – Intralesional tacrolimus or imiquimod cream 5 % applied nightly for 8‑12 weeks.

Emerging / experimental therapies

• Botulinum toxin A – May reduce tension on healing wounds and improve scar appearance.
• Microneedling combined with topical agents – Enhances drug delivery.
• Gene‑targeted therapy – Ongoing trials of TGF‑β inhibitors (e.g., fresolimumab).

Lifestyle and self‑care measures

• Protect scarred skin from sun (SPF 30+); UV exposure deepens pigmentation.
• Keep the area moisturized with non‑irritating emollients.
• Avoid unnecessary trauma, including tight clothing or aggressive scratching.

Living with Zigzag Scar Tissue (Keloid Variant)

Managing a keloid is as much about daily habits as it is about medical therapy.

Practical tips

• Massage – Gentle circular massage for 5‑10 minutes, 2–3 times daily, can soften tissue (use a silicone‑based cream).
• Heat therapy – Warm compresses for 10 minutes improve pliability before massage.
• Clothing choices – Wear loose‑fitting garments that do not rub against the scar.
• Monitor changes – Keep a photo log; note any rapid growth, pain spikes, or color changes.
• Psychological support – Counseling or support groups can reduce anxiety and improve quality of life.

Follow‑up schedule

After initiating treatment, most clinicians recommend visits every 4‑6 weeks for the first 3‑6 months, then every 6‑12 months for long‑term monitoring.

Prevention

Because keloids arise after skin injury, the best strategy is to minimize trauma and address wounds promptly.

• Optimize wound closure – Use subcuticular sutures, avoid excessive tension, and consider suturing techniques like buried vertical mattress.
• Early silicone or pressure therapy – Start within the first 2–4 weeks after surgery or injury for high‑risk individuals.
• Prophylactic steroid injections – In patients with a strong family history, a single intralesional triamcinolone dose at the time of wound closure can lower incidence.
• Sun protection – UV radiation stimulates fibroblast activity; apply broad‑spectrum sunscreen daily.
• Avoid unnecessary piercings or elective skin procedures unless absolutely needed.

Complications

If left untreated, zigzag keloids can lead to several issues:

• Progressive enlargement – May spread over large body areas, making surgical removal difficult.
• Functional limitation – When near joints (e.g., shoulder, knee), they can restrict range of motion.
• Chronic pain or pruritus – Can interfere with sleep and daily activities.
• Secondary infection – Ulcerated or broken scar tissue can become colonized.
• Psychosocial impact – Reduced self‑esteem, social anxiety, or depressive symptoms.

When to Seek Emergency Care

---

Sources: 1. Mayo Clinic. Keloid scars. 2023. 2. G. H. Kim et al., “Gender differences in keloid formation,” Dermatol Surg, 2021. 3. R. A. Ogawa, “Keloid and hypertrophic scar: A review of their differences,” Plastic Surg, 2022. 4. NIH National Center for Advancing Translational Sciences, “Keloid Overview,” 2022. 5. M. J. Lee et al., “TGF‑β signaling in keloid pathogenesis,” J Dermatol Sci, 2020. 6. CDC. Silicone gel therapy for scar management. 2022. 7. C. S. Al‑Ali et al., “Efficacy of intralesional triamcinolone for keloids,” Cleveland Clinic Journal of Medicine, 2021.

```